Description:

Vancomax (Vancomycin Intravenous Infusion IP) 500mg by John Lee is a sterile lyophilized powder for reconstitution into an intravenous solution. It is a glycopeptide antibiotic used to treat severe, life-threatening bacterial infections caused by susceptible Gram-positive organisms, particularly when other antibiotics are ineffective or contraindicated. Key indications include methicillin-resistant Staphylococcus aureus (MRSA) infections, endocarditis, bone/joint infections, sepsis, lower respiratory tract infections, skin/soft tissue infections, and Clostridium difficile-associated diarrhea (oral vancomycin for gut infections). It kills bacteria by inhibiting cell wall synthesis. In Ghana (Accra), it is a prescription injectable commonly used in hospitals for serious Gram-positive infections, especially MRSA or resistant strains.

Prescription:

Prescription-only (requires a doctor’s prescription in Ghana; dispensed by pharmacies or administered in hospitals/clinics with Rx; typically initiated and monitored by physicians or infectious disease specialists; not OTC due to serious infections, nephrotoxicity/ototoxicity risks, and need for therapeutic drug monitoring).

Therapeutic Category:

Glycopeptide Antibiotic (Cell wall synthesis inhibitor for Gram-positive bacterial infections.

Active Ingredients/Composition:

• Active ingredient: Vancomycin hydrochloride (sterile) IP – 500 mg per vial (powder for reconstitution). Other ingredients: None additional (sterile powder; reconstituted with sterile water for injection or compatible IV fluid to produce a clear solution).

Vitamins: None.

Minerals: None.

Variant:

• Vancomax 500mg Injection (standard 500mg vial; common pack 1 vial + water for injection + tray). Related variants: Vancomax 1g (1000mg vial), other vancomycin generics (500mg or 1g). The 500mg vial is the most common adult starting dose unit.

Consume Type:

Injectable – Intravenous (IV) infusion (powder reconstituted and diluted; administered only by healthcare professionals; slow infusion over 60 minutes or more; never IM or rapid bolus).

Directions/Usage: Administered only in hospital/clinic under medical supervision.

• Adults: Typical dose 15–20 mg/kg IV every 8–12 hours (actual body weight; max 2g/day).
  • Loading dose: Often 20–25 mg/kg for serious infections.
  • Infusion: Dilute in 100–250 ml compatible fluid (0.9% NaCl or 5% dextrose) and infuse over at least 60 minutes (to minimize infusion-related reactions).
• Children: Weight-based (10–15 mg/kg every 6–8 hours).
• Renal impairment: Reduce dose/frequency (e.g., every 24–48 hours or based on trough levels).
• Therapeutic drug monitoring: Trough levels 10–20 µg/ml (higher for severe infections); peak levels rarely needed.
• Duration: 7–14 days or longer depending on infection; complete full course.

Common Side Effects: Common:

• Infusion-related reactions (“red man syndrome”): Flushing, rash, itching, hypotension (minimized by slow infusion).
• Nephrotoxicity (kidney damage – monitor renal function).
• Ototoxicity (hearing loss/tinnitus – rare).
• Nausea, vomiting.
• Phlebitis at infusion site. Rare/serious (seek immediate help): Severe hypersensitivity (anaphylaxis), severe skin reactions (DRESS, Stevens-Johnson syndrome), thrombocytopenia, neutropenia, or superinfections.

Package Type:

Glass vial of powder (500mg vancomycin hydrochloride; single vial with water for injection + tray; packs often 1 vial per box or multi-vial cartons; labelled with reconstitution instructions and warnings).

Storage Advice: Store unopened vials at room temperature (below 25–30°C) in original packaging, protected from light. Do not freeze. Reconstituted solution: Use immediately or refrigerate (2–8°C) for up to 24 hours (check label). Diluted infusion: Use within 24 hours refrigerated or 4–8 hours at room temperature.

Safety Advice:

• Administered only under medical supervision (risk of nephrotoxicity, ototoxicity, and infusion reactions – slow infusion over ≥60 minutes).
• Contraindicated in hypersensitivity to vancomycin.
• Caution in renal impairment (dose adjustment required), hearing loss history, concurrent nephrotoxic/ototoxic drugs (e.g., aminoglycosides, amphotericin B), or elderly patients.
• Monitor renal function (creatinine, BUN), hearing, and trough levels (10–20 µg/ml) during therapy.
• Infusion reactions minimized by slow infusion and premedication (e.g., antihistamines) if needed.
• If rash, fever, tinnitus, reduced urine output, or severe hypotension occurs, stop use and seek urgent care.
• Keep out of reach of children (overdose risk).

Product Substitutes: Similar vancomycin injections in Ghana include:

• Generic vancomycin 500mg or 1g IV powder (various importers).
• Vancomax 500mg (John Lee brand, same product).
• Vancocin (original brand if stocked).
• Other brands like Vancoled or local generics. Consult doctor/pharmacist in Accra (e.g., hospital pharmacy) for alternatives.

Manufacturer/Marketer:

John lee Pharmaceuticals Pvt. Ltd. (India; primary manufacturer of Vancomax Vancomycin Injection). Marketed/distributed in Ghana by local importers/pharmacies (widely stocked as imported generic).

Country of Origin:

India (manufactured by Johnlee Pharmaceuticals Pvt. Ltd.; imported to Ghana and available in local pharmacies/hospitals).